Skip to main content
Top
Published in: European Radiology 4/2018

01-04-2018 | Magnetic Resonance

Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index

Authors: Mengtian Sun, Jingliang Cheng, Yong Zhang, Jie Bai, Feifei Wang, Yun Meng, Zhenqian Li

Published in: European Radiology | Issue 4/2018

Login to get access

Abstract

Objectives

We investigated the correlation between the apparent diffusion coefficient (ADC) and Ki-67 index using diffusion-weighted whole-body imaging with background body signal suppression (DWIBS), and their utility in evaluating malignant lymphoma cell proliferation.

Materials and Methods

Seventy-four patients with malignant lymphoma underwent DWIBS within 1 week before pathological confirmation. The ADC value was measured at the site of the pathological examination, and specimens were also stained with Ki-67. The ADC values and Ki-67 indices in aggressive non-Hodgkin's lymphoma (NHL), indolent NHL, and Hodgkin's lymphoma (HL) were compared using Spearman's rank correlation coefficient and the Kruskal-Wallis test.

Results

The Ki-67 indices and ADC values were inversely correlated (r = -0.289, p = 0.0125); the differences in the Ki-67 index between aggressive NHL, indolent NHL, and HL were significant (p < 0.001); this was confirmed by the Nemenyi test except for indolent NHL vs. HL. The ADC values were significantly different between the types of lymphoma (p = 0.013); the Nemenyi test showed a significant difference only between aggressive NHL and HL.

Conclusions

The Ki-67 indices and ADC values are inversely correlated in patients with lymphoma, combining DWIBS and ADC values can evaluate the proliferation level of malignant lymphoma cells noninvasively.

Key points

• By using DWIBS, malignant lymphoma cell proliferation can be assessed noninvasively.
• The ADC value and Ki-67 index are significantly and inversely correlated.
• The ADC values were lower in aggressive NHL than in HL.
• The ADC values of aggressive and indolent NHL were not significantly different.
Literature
2.
go back to reference Abdulqadhr G, Molin D, Aström G et al (2011) Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol 52:173–180CrossRefPubMed Abdulqadhr G, Molin D, Aström G et al (2011) Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol 52:173–180CrossRefPubMed
3.
go back to reference Gu J, Chan T, Zhang J et al (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 197:W384–W391CrossRefPubMed Gu J, Chan T, Zhang J et al (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 197:W384–W391CrossRefPubMed
4.
go back to reference Chen L, Liu M, Bao J et al (2013) The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis. PLoS One 8:e79008CrossRefPubMedPubMedCentral Chen L, Liu M, Bao J et al (2013) The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis. PLoS One 8:e79008CrossRefPubMedPubMedCentral
5.
go back to reference Jeon JY, Chung HW, Lee MH et al (2016) Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions. Br J Radiol 89:20150929CrossRefPubMedPubMedCentral Jeon JY, Chung HW, Lee MH et al (2016) Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions. Br J Radiol 89:20150929CrossRefPubMedPubMedCentral
6.
go back to reference Horger M, Claussen C, Kramer U et al (2014) Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging. Eur J Radiol 83:1655–1664CrossRefPubMed Horger M, Claussen C, Kramer U et al (2014) Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging. Eur J Radiol 83:1655–1664CrossRefPubMed
7.
go back to reference Barajas RF Jr, Rubenstein JL, Chang JS et al (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 31:60–66CrossRefPubMed Barajas RF Jr, Rubenstein JL, Chang JS et al (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 31:60–66CrossRefPubMed
8.
go back to reference Valles FE, Perez-Valles CL, Regalado S et al (2013) Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. AJNR Am J Neuroradiol 34:35–40CrossRefPubMed Valles FE, Perez-Valles CL, Regalado S et al (2013) Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. AJNR Am J Neuroradiol 34:35–40CrossRefPubMed
9.
10.
go back to reference Broyde A, Boycov O, Strenov Y et al (2009) Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Am J Hematol 84:338–343CrossRefPubMed Broyde A, Boycov O, Strenov Y et al (2009) Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Am J Hematol 84:338–343CrossRefPubMed
11.
go back to reference Cuenca X, Xhaard A, Mounier N (2009) Prognostic factors in Hodgkin and non-Hodgkin lymphomas. Bull Cancer 96:461–473PubMed Cuenca X, Xhaard A, Mounier N (2009) Prognostic factors in Hodgkin and non-Hodgkin lymphomas. Bull Cancer 96:461–473PubMed
12.
go back to reference Swerdlow SH, Campo E, Harris NL et al (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France Swerdlow SH, Campo E, Harris NL et al (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France
13.
go back to reference Huang HH, Xiao F, Chen FY et al (2012) Reassessment of the prognostic value of the International Prognostic Index and the revised InternationalPrognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study. Exp Ther Med 4:475–480CrossRefPubMedPubMedCentral Huang HH, Xiao F, Chen FY et al (2012) Reassessment of the prognostic value of the International Prognostic Index and the revised InternationalPrognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study. Exp Ther Med 4:475–480CrossRefPubMedPubMedCentral
14.
go back to reference Sehn LH, Berry B, Chhanabhai M et al (2007) The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109:1857–1861CrossRefPubMed Sehn LH, Berry B, Chhanabhai M et al (2007) The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109:1857–1861CrossRefPubMed
15.
go back to reference Prochazka KT, Melchardt T, Posch F et al (2016) NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. Br J Cancer 115:1264–1272CrossRefPubMedPubMedCentral Prochazka KT, Melchardt T, Posch F et al (2016) NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. Br J Cancer 115:1264–1272CrossRefPubMedPubMedCentral
16.
go back to reference Gerdes J, Schwab U, Lemke H et al (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20CrossRefPubMed Gerdes J, Schwab U, Lemke H et al (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20CrossRefPubMed
17.
go back to reference Jakovic LR, Mihaljevic BS, Jovanovic MD et al (2007) The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG). Med Oncol 24:45–53CrossRefPubMed Jakovic LR, Mihaljevic BS, Jovanovic MD et al (2007) The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG). Med Oncol 24:45–53CrossRefPubMed
18.
go back to reference Hoster E, Rosenwald A, Berger F et al (2016) Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. J Clin Oncol 34:1386–1394CrossRefPubMed Hoster E, Rosenwald A, Berger F et al (2016) Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. J Clin Oncol 34:1386–1394CrossRefPubMed
20.
go back to reference Huang Z, Xu X, Meng X et al (2015) Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma. Eur J Radiol 84:2464–2469CrossRefPubMed Huang Z, Xu X, Meng X et al (2015) Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma. Eur J Radiol 84:2464–2469CrossRefPubMed
21.
go back to reference Meng X, Li H, Kong L et al (2016) MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF. J Magn Reson Imaging 44:594–600CrossRefPubMed Meng X, Li H, Kong L et al (2016) MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF. J Magn Reson Imaging 44:594–600CrossRefPubMed
22.
go back to reference Guo AC, Cummings TJ, Dash RC et al (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177–183CrossRefPubMed Guo AC, Cummings TJ, Dash RC et al (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177–183CrossRefPubMed
23.
go back to reference Wu X, Pertovaara H, Dastidar P et al (2013) ADC measurements in diffuse large B-cell lymphoma and follicular lymphoma: a DWI and cellularity study. Eur J Radiol 82:e158–e164CrossRefPubMed Wu X, Pertovaara H, Dastidar P et al (2013) ADC measurements in diffuse large B-cell lymphoma and follicular lymphoma: a DWI and cellularity study. Eur J Radiol 82:e158–e164CrossRefPubMed
24.
go back to reference Fernebro J, Engellau J, Persson A et al (2007) Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center. APMIS 115:707–712CrossRefPubMed Fernebro J, Engellau J, Persson A et al (2007) Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center. APMIS 115:707–712CrossRefPubMed
Metadata
Title
Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index
Authors
Mengtian Sun
Jingliang Cheng
Yong Zhang
Jie Bai
Feifei Wang
Yun Meng
Zhenqian Li
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 4/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5135-y

Other articles of this Issue 4/2018

European Radiology 4/2018 Go to the issue